Patricia Roxburgh
Impact in
- Reproductive Medicine top 5%
- Ovarian cancer diagnosis and treatment
- Oncology top 5%
- PARP inhibition in cancer therapy
- Cancer Immunotherapy and Biomarkers
- CAR-T cell therapy research
Papers in
- Oncology 25
- PARP inhibition in cancer therapy 12
- Cancer Immunotherapy and Biomarkers 6
- Pancreatic and Hepatic Oncology Research 3
-
- Ovarian cancer diagnosis and treatment 12
- Co-authors
- Thomas R. Jeffry Evans (1 shared paper)Michelle Ferguson (3 shared papers)Hendrik‐Tobias Arkenau (2 shared papers)Susana N. Banerjee (3 shared papers)Karen H. Vousden (3 shared papers)Andreas K Hock (3 shared papers)Kevin Joseph Harrington (1 shared paper)Mokdad Mezna (2 shared papers)
- Journals
- Annals of Oncology (6 papers)Clinical Cancer Research (6 papers)International Journal of Gynecological Cancer (4 papers)European Journal of Cancer (3 papers)Nature Communications (3 papers)
- Partner nations
- United KingdomUnited StatesAustralia
In The Last Decade
Patricia Roxburgh
49 papers receiving 1.3k citations
Peers
Comparison fields: 5 of 72
- Reproductive Medicine 238
- Oncology 631
- Cancer Research 157
- Immunology 154
- Genetics 200
Countries citing papers authored by Patricia Roxburgh
This map shows the geographic impact of Patricia Roxburgh's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Patricia Roxburgh with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Patricia Roxburgh more than expected).
Fields of papers citing papers by Patricia Roxburgh
This network shows the impact of papers produced by Patricia Roxburgh. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Patricia Roxburgh. The network helps show where Patricia Roxburgh may publish in the future.
Co-authors
The 25 scholars most cited alongside Patricia Roxburgh, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 55 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2021 | 187 | |
| 2 | 2010 | 105 | |
| 3 | 2022 | 91 | |
| 4 | 2019 | 84 | |
| 5 | 2008 | 80 | |
| 6 | 2010 | 77 | |
| 7 | 2017 | 68 | |
| 8 | 2020 | 63 | |
| 9 | 2023 | 57 | |
| 10 | 2020 | 52 | |
| 11 | 2021 | 43 | |
| 12 | 2012 | 35 | |
| 13 | 2021 | 35 | |
| 14 | 2022 | 33 | |
| 15 | 2022 | 29 | |
| 16 | 2024 | 26 | |
| 17 | 2012 | 23 | |
| 18 | 2024 | 20 | |
| 19 | 2013 | 19 | |
| 20 | 2022 | 19 |
About Patricia Roxburgh
Patricia Roxburgh is a scholar working on Oncology, Reproductive Medicine, Cancer Research, Pulmonary and Respiratory Medicine and Pathology and Forensic Medicine, having authored 55 papers that have together received 1.3k indexed citations. Recurring topics across this work include Ovarian cancer diagnosis and treatment (12 papers), PARP inhibition in cancer therapy (12 papers), Cancer Genomics and Diagnostics (10 papers), Cancer Immunotherapy and Biomarkers (6 papers), Renal cell carcinoma treatment (4 papers), Virus-based gene therapy research (3 papers), Pancreatic and Hepatic Oncology Research (3 papers) and BRCA gene mutations in cancer (3 papers). The work is most often cited by research in Reproductive Medicine (238 citations), Oncology (631 citations), Cancer Research (157 citations), Immunology (154 citations) and Genetics (200 citations). Patricia Roxburgh has collaborated with scholars based in United Kingdom, United States and Australia. Frequent co-authors include Thomas R. Jeffry Evans, Michelle Ferguson, Hendrik‐Tobias Arkenau, Susana N. Banerjee, Karen H. Vousden, Andreas K Hock, Kevin Joseph Harrington, Mokdad Mezna, Peter M. Fischer and Katie R. Twigger. Their work appears in journals such as Annals of Oncology, Clinical Cancer Research, International Journal of Gynecological Cancer, European Journal of Cancer and Nature Communications.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.